In 2018, WVE was joined by environmental, health, and justice organizations from across the nation to express alarm about the lack of ingredient transparency, and toxic chemicals, in Summer’s Eve products.
And the coalition of support continues!
Today, leading researchers, scientists and healthcare providers joined us in an open letter (see below) to tell Prestige Consumer Healthcare, the makers of Summer’s Eve, that toxic and secret ingredients in personal care products are unacceptable.
Scientists are clearly concerned about the impact chemicals in these products may be having on our health. It’s long past time Summer’s Eve meets our demands to disclose all ingredients (including fragrances) in Summer’s Eve douches, washes, wipes and sprays, and eliminate the presence of all chemicals linked to cancer, fertility effects and other serious health concerns.
Please add your voice to the letter and sign-on today!
Taking care of our bodies – however we choose – should never put our heath at risk.
(If outside of the United States, please click here to take action.)
Your voice makes a difference. In the last two years Summer’s Eve has reformulated their products to remove dangerous dyes and other harmful preservatives. But there are still critical and considerable disclosure and ingredient safety concerns, not to mention the company’s harmful marketing that exploits decades of stigma meant to make people feel ashamed of their bodies.
Whether you use these products or not, it is unacceptable that a company is allowed to push a product under the guise of vaginal and sexual health, when in fact these products may pose a threat to our health.
October 22, 2019
President & CEO
Prestige Consumer Healthcare, Inc.
660 White Plains Road
Tarrytown, NY 10591
Dear Mr. Lombardi:
On behalf of the undersigned scientists, researchers and academics we are writing to urge you to disclose all ingredients (including fragrances) in Summer’s Eve intimate care products, eliminate the presence of chemicals linked to cancer, fertility effects and other serious health concerns and conduct research to better understand potential health harms from the use of intimate care products.
Summer’s Eve is the leading brand in intimate care products. These products are specifically intended for use on vaginal and vulvar tissue, which constitute a highly permeable route of chemical exposure. Furthermore, a considerable body of research has associated use of douches and other vaginal cleansers with greater risk of bacterial vaginosis and vulvovaginal candidiasis.[i][ii][iii][iv]Yet, there is very little research examining the potential for chemicals in douches and vaginal cleansers to disrupt the vaginal microbiome, possibly leading to greater risk of infection.[v] In addition, douching has been linked to increased body burden of harmful chemicals, such as phthalates.[vi]This makes exposure to harmful chemicals in Summer’s Eve and other intimate products a vital public health issue.
Chemicals of concern in Summer’s Eve Products
Our 2018 store survey of ingredients in intimate care products showed that Summer’s Eve products still contain chemicals of concern, including:
Octoxynol-9: (Present in Summer’s Eve Douche and Body Powder) A potent contraceptive drug that effectively kills sperm. However, intimate care products containing octoxynol-9 are not considered contraceptives, nor are they required to have any caution labeling to their potential effect on a woman’s fertility. Women who use vaginal products containing octoxynol-9 may be unaware that exposure to this ingredient may impact their ability to get pregnant. Octoxynol-9 is also chemically similar to nonoxynol-9. Use of vaginally applied products containing nonoxynol-9 is known to both cause vaginal irritation [vii], and significantly increase risks of HIV transmission.[viii] Octoxynol-9 is simply not an appropriate ingredient for an intimate care product.
Fragrance & Ingredient Transparency
Fragrance can be made up of hundreds of different ingredients, many of which are linked to serious health problems, from skin irritation to hormone disruption and breast cancer.[ix] Summer’s Eve brand does not currently disclose the specific fragrance ingredients used in each product, making it impossible for users of these products to avoid fragrance chemicals of concern. For example, there is a variety of allergens very commonly found in fragrance and exposure in sensitized individuals could lead to considerable discomfort. Your customers with allergies deserve the information necessary to avoid the fragrance allergens of particular concern to them.
Undisclosed fragrance chemicals are of special concern in feminine care products given research findings linking vaginal douching with higher levels of a certain phthalate (DEP), a known fragrance ingredient, in the body. Phthalates, in general, are chemicals of concern for women’s health because they are endocrine disruptors and are linked to harmful health effects including reproductive and developmental harm as well as chronic disease risks in adults.[x]
Users of intimate care products have the right to know which chemicals they are being exposed to. Personal wipes, douches and powders are designed to have direct contact with sensitive vulvar and vaginal tissue that readily absorbs chemicals. We believe chemicals linked to cancer and reproductive harm do not belong in these products, even at very low concentrations. Major manufacturers of personal care products such as Procter & Gamble and Unilever have recently committed to disclosing individual fragrance ingredients on every product. Similarly, as you may know, any cosmetic products sold in the European Union must disclose the presence of fragrance allergens on the label. Numerous international manufacturers are also providing the same information for their U.S. customers. Disclosing fragrance ingredients is both feasible and the right thing to do for customers.
Lastly, as the makers of the leading brand in intimate care products, Summer’s Eve has a responsibility to its customers to investigate and better understand the links between use of intimate care products and adverse health outcomes such as bacterial vaginosis and vulvovaginal candidiasis. These conditions are very common, and cause considerable morbidity globally.[xi][xii] Your products may be contributing significantly to these adverse conditions. You have both the moral and legal responsibility to produce safe and harmless products for your customers. Further investigations into the prevalence of these conditions among users of your products are needed with greater attention to any modifications that could be made to improve product safety.
For these reasons, we urge Prestige Consumer Healthcare to:
- Disclose all ingredients, including fragrance ingredients, in all of your intimate care products, and highlight fragrance allergens in those products.
- Eliminate the presence of ingredients and contaminants linked to cancer and other serious health problems from all of your intimate care products.
- Develop and disclose a chemical safety policy for Summer’s Eve products to address the use of known and emerging chemicals of concern.
- Conduct research to better understand potential health harms from the use of intimate care products to ensure safer products.
We understand that at Prestige Consumer Healthcare you focus on products “to better improve the lives of our customers and their world.” Indeed, it is your mission to “preserve consumer trust by continuing to provide products stewarded with their needs in mind.” We appreciate these laudable goals and encourage you to apply them to improve the safety of Summer’s Eve products.
We would be happy to discuss the concerns raised in this letter with you further. Please contact Jamie McConnell, Director of Programs and Policy at (406) 543-3747 or firstname.lastname@example.org at your earliest convenience to set up a time for a call or meeting.
Director of Science and Research
Women’s Voices for the Earth
Note: Institutional affiliations are listed for identification purposes only.
Ann Blake, Ph.D.
Environmental & Public Health Consulting
Ted Schettler MD, MPH
Science and Environmental Health Network
Meg Schwarzman, MD, MPH
University of California, Berkeley School of Public Health
Steven G. Gilbert, PhD, DABT
University of Washington
Nancy Reame, MSN, PhD Emerita Professor
Columbia University, and the University of Michigan
New York, NY and Ann Arbor, MI
Robin M. Whyatt, DrPH, Professor Emeritus
Mailman School of Public Health, Columbia University
Dr Camilla Mork Rostvik
University of St Andrews
Carol Rinkleib Ellison, Ph.D.
AASECT Certified Sexuality Educator & Diplomate of Sex Therapy
Aly Cohen MD FACR
The Smart Human LLC.
Sharima Rasanayagam, PhD
Breast Cancer Prevention Partners
San Francisco, California
St Andrews, UK
Joan C. Chrisler, Ph.D., Professor Emerita
University of British Columbia
Magdalen Edmunds, MD,MPH
University of California, San Francisco
San Francisco, CA
University of Massachusetts Boston
New York, NY
Paula J. Caplan
Gina Solomon, MD, MPH
University of California, San Francisco
San Francisco, CA
West Lafayette, IN
Margaret L. (Peggy) Stubbs, PhD Professor Emerita
Medicina de Mujer
Ami R. Zota, ScD, MS
George Washington University
CR Research / Consulting
Jill M. Wood, PhD
State College, PA
Nicole Acevedo, Ph.D.
Elavo Mundi Solutions, LLC
The Real Period Project CIC
[i]Brotman, R. M., Ghanem, K. G., Klebanoff, M. A., Taha, T. E., Scharfstein, D. O., & Zenilman, J. M. (2008). The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. American Journal of Obstetrics and Gynecology, 198(6), 628.e1-628.e7. doi:10.1016/j.ajog.2007.11.043
[ii]Brotman, R. M., Klebanoff, M. A., Nansel, T. R., Andrews, W. W., Schwebke, J. R., Zhang, J., … Scharfstein, D. O.
(2008). A Longitudinal Study of Vaginal Douching and Bacterial Vaginosis–A Marginal Structural Modeling Analysis. American Journal of Epidemiology, 168(2), 188-196. doi:10.1093/aje/kwn103
[iii]Ness, R. B., Hillier, S. L., Richter, H. E., Soper, D. E., Stamm, C., McGregor, J., … Rice, P. (2002). Douching in Relation to Bacterial Vaginosis, Lactobacilli, and Facultative Bacteria in the Vagina. Obstetrics & Gynecology,
100(4), 765-772. doi:10.1097/00006250-200210000-00025
[iv]Heng, L. S., Yatsuya, H., Morita, S., & Sakamoto, J. (2010). Vaginal Douching in Cambodian Women: Its Prevalence and Association With Vaginal Candidiasis. Journal of Epidemiology, 20(1), 70-76. doi:10.2188/jea.je20081046
[vi]Branch, F., Woodruff, T. J., Mitro, S. D., & Zota, A. R. (2015). Vaginal douching and racial/ethnic disparities in phthalates exposures among reproductive-aged women: National Health and Nutrition Examination Survey 2001–2004. Environmental Health, 14(1). doi:10.1186/s12940-015-0043-6
[vii]Roddy, R. E., Cordero, M., Cordero, C., & Fortney, J. A. (1993). A Dosing Study of Nonoxynol-9 and Genital Irritation. International Journal of STD & AIDS, 4(3), 165-170. doi:10.1177/095646249300400308
[viii]Van Damme, L., Ramjee, G., Alary, M., Vuylsteke, B., Chandeying, V., Rees, H., … Laga, M. (2002). Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. The Lancet, 360(9338), 971-977. doi:10.1016/s0140-6736(02)11079-8
[x]Branch, F., Woodruff, T. J., Mitro, S. D., & Zota, A. R. (2015). Vaginal douching and racial/ethnic disparities in phthalates exposures among reproductive-aged women: National Health and Nutrition Examination Survey 2001–2004. Environmental Health, 14(1). doi:10.1186/s12940-015-0043-6
[xi]Foxman, B., Muraglia, R., Dietz, J., Sobel, J. D., & Wagner, J. (2013). Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States. Journal of Lower Genital Tract Disease, 17(3), 340-345. doi:10.1097/lgt.0b013e318273e8cf
[xii]Hoffmann, J. N., You, H. M., Hedberg, E. C., Jordan, J. A., & McClintock, M. K. (2014). Prevalence of Bacterial Vaginosis and Candida among Postmenopausal Women in the United States. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 69(Suppl 2), S205-S214. doi:10.1093/geronb/gbu105